RNAi-mediated COPS3 gene silencing inhibits metastasis of osteogenic sarcoma cells
Open Access
- 25 March 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 18 (6), 450-456
- https://doi.org/10.1038/cgt.2011.16
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and CancerPharmacological Reviews, 2008
- Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastasesClinical & Experimental Metastasis, 2007
- High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcomaGene, 2007
- Over‐expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcomaInternational Journal of Cancer, 2007
- TP53 Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter StudyJournal of Clinical Oncology, 2005
- Overexpression through amplification of genes in chromosome region 17p11.2∼p12 in high-grade osteosarcomaCancer Genetics and Cytogenetics, 2004
- The COP9 SignalosomeAnnual Review of Cell and Developmental Biology, 2003
- Frequent amplification and rearrangement of chromosomal bands 6p12‐p21 and 17p11.2 in osteosarcomaGenes, Chromosomes and Cancer, 2003
- Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?Cancer, 2002
- DNA sequence copy number increase at 8q: A potential new prognostic marker in high-grade osteosarcomaInternational Journal of Cancer, 1999